尔康制药 (300267)

HUNAN ER-KANG PHARMACEUTICAL CO.,LTD.

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 206260.49
  • Circulating A-Shares(W): 142239.19
  • Earnings Per Share(RMB): 0.0192
  • Net Assets Per Share(RMB): 2.1670
  • Operating Revenue(W RMB): 100642.37
  • Total Profit(W RMB): 3075.02
  • Net Profit Attributable to Parent(W RMB): 3957.59
  • Net Profit Growth Rate(%): 255.40
  • Weighted Return on Equity(%): 0.8900
  • Operating Cash Flow Per Share(RMB): 0.1030
  • Undistributed Profit Per Share(RMB): 0.5845
  • Capital Reserve Per Share(RMB): 0.4943

2. Main Business

The main business covers:

  • Production and sales of pharmaceutical excipients
  • Production and sales of active pharmaceutical ingredients (APIs)
  • Production and sales of finished drugs
  • Production and sales of new energy materials

3. Company Basic Information

  • Company Name: Hunan Er-kang Pharmaceutical Co., Ltd.
  • Listing Date: 2011-09-27
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 167 Kangping Road, Liuyang Economic Development Zone, Changsha City, Hunan Province, China
  • Website: www.hnerkang.com
  • Company Profile: The company's predecessor was Hunan Erkang Pharmaceutical Co., Ltd., established on October 22, 2003. On October 23, 2010, Erkang Limited held a shareholders' meeting where all shareholders unanimously agreed to transform the company into a joint stock limited company. On October 28, 2010, all shareholders of Erkang Limited signed the "Sponsor Agreement," converting the audited net assets of Hunan Erkang Pharmaceutical Co., Ltd. as of September 30, 2010, amounting to 139,586,938.57 yuan, into 138 million shares of the company at a ratio of 1:0.9886, with the remaining 1,586,938.57 yuan credited to capital reserve. The company was registered with the Changsha Administration for Industry and Commerce on November 8, 2010, with registration number 430181000010054, registered capital of 138 million yuan, company address at Changsha Liuyang Biomedical Industrial Park, and legal representative Shuai Fangwen.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hunan Shuaijia Investment Co., Ltd. General Legal Person 13295.10 9.35
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 2587.86 1.82
3 Hunan Jinyang Investment Group Co., Ltd. General Legal Person 1273.75 0.90

5. Concept Sectors

  • Lithium Battery
  • Vitamins
  • Artificial Intelligence
  • Industrial Hemp
  • NMN Concept
  • Lithium Mining
  • Helicobacter Pylori
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • Low-Profit Stock
  • Consecutive Losses
  • High Pledged Shares
  • ChiNext Pharmaceuticals
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information